Basaglar and Vitreous floaters - a phase IV clinical study of FDA data

Summary:

Vitreous floaters is reported as a side effect among people who take Basaglar (insulin glargine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Humalog, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Vitreous floaters when taking Basaglar. It is created by eHealthMe based on reports of 19,751 people who have side effects when taking Basaglar from the FDA, and is updated regularly.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

What is Vitreous floaters?

Vitreous floaters (spots before the eyes) is found to be associated with 830 drugs and 838 conditions by eHealthMe. Check the latest studies of Vitreous floaters.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

19,751 people reported to have side effects when taking Basaglar.
Among them, 12 people (0.06%) have Vitreous floaters.

Among these 12 people:

How long have people been on Basaglar when they have Vitreous floaters? *

What is the gender of people who have Vitreous floaters when taking Basaglar? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Vitreous floaters when taking Basaglar? *

What are other drugs people take besides Basaglar? *

What are other side effects people have besides Vitreous floaters? *

Blood Glucose Increased: 4 people, 33.33%
Eye Haemorrhage (bleeding in the eye): 3 people, 25.00%
Vision Blurred: 3 people, 25.00%
Visual Impairment: 3 people, 25.00%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 16.67%
Blindness: 2 people, 16.67%
Blindness Unilateral: 2 people, 16.67%
Blood Glucose Decreased: 2 people, 16.67%
Cataract (clouding of the lens inside the eye): 2 people, 16.67%
Drug Ineffective: 2 people, 16.67%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 41.67%
Vertigo Positional: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Blood Glucose Increased: 1 person, 8.33%
Blood Glucose Abnormal: 1 person, 8.33%
Age-Related Macular Degeneration: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and have Vitreous floaters?

- Check whether Vitreous floaters is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Basaglar:

Basaglar (19,807 reports)

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vitreous floaters:

Vitreous floaters (830 drugs)

Browse all the conditions that are associated with Vitreous floaters:

Vitreous floaters (838 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine (the active ingredients of Basaglar) and Basaglar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.